Publication | Closed Access
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients
42
Citations
30
References
2018
Year
In patients on hemodialysis, 24-week treatment with ferric citrate hydrate resulted in significant reduction in FGF23 and ERI independently of serum phosphate level.
| Year | Citations | |
|---|---|---|
Page 1
Page 1